Browse by Medical Category
Dr. Pandharipande practices abdominal imaging at MGH and conducts research at the MGH Institute for Technology Assessment. Her career goal is to improve the outcomes of cancer patients by defining the best roles for imaging in cancer care.
Go To Programs
Dr. Pandharipande is an Assistant Professor of Radiology at Harvard Medical School, an Assistant Radiologist in Abdominal Imaging at Massachusetts General Hospital, and a Senior Scientist at the MGH Institute for Technology Assessment. She is a graduate of Cornell University (BA), Cornell University Medical College (MD), and the Harvard School of Public Health (MPH). She completed her residency in diagnostic radiology at NYU, and an NCI-sponsored fellowship in cancer outcomes research and abdominal imaging at MGH. Dr. Pandharipande's career goal is to improve cancer outcomes by defining the best roles for imaging-based technologies in the care of cancer patients. She is currently the Principal Investigator of an NIH/NCI K07 Award in which she is evaluating the cost-effectiveness of imaging-guided RF ablation for kidney tumors. Dr. Pandharipande is also clinically active within the Abdominal Imaging Division at MGH, where she interprets imaging studies and trains residents and fellows.
Immediate health risks supersede lifetime radiation-induced cancer risk in patients undergoing CT surveillance for testicular cancer, according to a new study.
The lifetime risks of cancer from medical radiation may be overemphasized relative to more immediate health risks, according to a new study.
Back to Top